IQVIA Holdings Inc. which can be found using ticker (IQV) now have 20 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 281 and 215 and has a mean target at $250.84. Given that the stocks previous close was at $216.29 this would imply there is now a potential upside of 16.0%. The day 50 moving average is $215.59 and the 200 day moving average is $209.11. The total market capitalization for the company now stands at 40.25B. The stock price for the company is currently is currently 216.93 USD
The potential market cap would be $46,680,828,958 based on the market consensus.
The company has a dividend yield of 2.93%. Other points of data to note are a P/E ratio of 38.81, revenue per share of 79.12 and a 4.79% return on assets.
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.
